PATENT CLAIM ANALYSIS

Application Number: 15967187
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "210000"]

Abstract:
Compounds having a structure of formula (I), including stereoisomers and pharmaceutically acceptable salts and solvates thereof: wherein R 1  is as defined herein. Such compounds are inhibitors of the vesicular monoamine transporter 2 (VMAT2) and have utility for treating, for example, hyperkinetic disorders. Also disclosed are compositions containing these compounds in combination with a pharmaceutically acceptable carrier or diluent, as well as methods relating to the use in a subject in need thereof.

Claim (Index 6):
The compound of  claim 5 , wherein the compound is selected from one of the following: Cpd. O\u2014R 1 2-1\u2002   2-2\u2002   2-3\u2002   2-4\u2002   2-5\u2002   2-7\u2002   2-8\u2002   2-9\u2002   2-10   2-13   2-14   2-15   2-16   2-17   2-19   2-23   2-24   2-28   2-29   2-30   2-32   2-33   2-34   2-35   2-36   2-39   3-1\u2002   3-2\u2002   3-3\u2002   3-7\u2002   3-8\u2002   3-9\u2002   3-10   3-11   3-12   3-13   4-2\u2002   4-9\u2002   4-10   4-12   4-14   4-16   4-17   4-19   4-23   4-24   4-28   4-30   4-31   4-33   4-34   4-36   4-37   4-38

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.37097
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15627145', '15017480', '15116786', '11937445', '13237709']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8227796498122357
- 35 USC 102 Novelty (BERT): 0.6048739813485334
- Combined Prediction Score: 0.8009890829658656
- Mean Citation Score: 422.62164999999993
- Max Citation Score: 558.68744
- Similarity Product: 465.9774217179585

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test